NCT07468071
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07468071
Title Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments (KontRASt-R)
Acronym KontRASt-R
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN | BEL

Facility Status City State Zip Country Details
Novartis Investigative Site RECRUITING Sint-Niklaas Oost Vlaanderen 9100 Belgium Details
Novartis Investigative Site RECRUITING Montreal Quebec H4A 3J1 Canada Details
Novartis Investigative Site RECRUITING Guangzhou Guangdong 510080 China Details
Novartis Investigative Site RECRUITING Kashiwa Chiba 277-8577 Japan Details
Novartis Investigative Site RECRUITING Koto Ku Tokyo 1358550 Japan Details
Novartis Investigative Site RECRUITING Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site ACTIVE_NOT_RECRUITING Seoul 03080 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field